Clinical trial
Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects…
NCT00380042 · Northstar Neuroscience, Industry · Terminated
Key facts
| NCT number | NCT00380042 |
|---|---|
| Title | Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder |
| Official title | Feasibility Study of the Safety and Effectiveness of Cortical Stimulation for Subjects With Major Depressive Disorder |
| Acronym | PROSPECT |
| Lead sponsor | Northstar Neuroscience, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depression, Depressive Disorder |
| Intervention type | Device |
| Interventions | Cortical Stimulation, Sham |
| Enrollment | 12 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Sep 25, 2006 |
| Last update posted | Dec 31, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: